T Cell Functions in Granulocyte/macrophage Colony-stimulating Factor Deficient Mice
Overview
Authors
Affiliations
Immunological functions were analyzed in mice lacking granulocyte/macrophage colony-stimulating factor (GM-CSF). The response of splenic T cells to allo-antigens, anti-mouse CD3 mAb, interleukin 2 (IL-2), or concanavalin A was comparable in GM-CSF +/+ and GM-CSF -/- mice. To investigate the responses of CD8(+) and CD4+ T cells against exogenous antigens, mice were immunized with ovalbumin peptide or with keyhole limpet hemocyanin (KLH). Cytotoxic CD8+ T cells with specificity for ovalbumin peptide could not be induced in GM-CSF -/- mice. After immunization with KLH, there was a delay in IgG generation, particularly IgG2a, in GM-CSF -/- mice. Purified CD4+ T cells from GM-CSF -/- mice immunized with KLH showed impaired proliferative responses and produced low amounts of interferon-gamma (IFN-gamma) and IL-4 when KLH-pulsed B cells or spleen cells were used as antigen presenting cells (APC). When enriched dendritic cells (DC) were used as APC, CD4+ T cells from GM-CSF -/- mice proliferated as well as those from GM-CSF +/+ mice and produced high amounts of IFN-gamma and IL-4. To analyze the rescue effect of DC on CD4(+) T cells, supernatants from (i) CD4(+) T cells cultured with KLH-pulsed DC or (ii) DC cultured with recombinant GM-CSF were transferred to cultures of CD4(+) T cells and KLH-pulsed spleen cells from GM-CSF -/- mice. Supernatants from both DC sources contained a factor or factors that restored proliferative responses and IFN-gamma production of CD4(+) T cells from GM-CSF -/- mice.
Lian G, Wang Q, Mak T, Huang X, Yu X, Lan H Cell Mol Life Sci. 2024; 81(1):262.
PMID: 38878186 PMC: 11335298. DOI: 10.1007/s00018-024-05290-4.
Arumugam P, Carey B, Wikenheiser-Brokamp K, Krischer J, Wessendarp M, Shima K Mol Ther Methods Clin Dev. 2024; 32(2):101213.
PMID: 38596536 PMC: 11001781. DOI: 10.1016/j.omtm.2024.101213.
Van Dis E, Fox D, Morrison H, Fines D, Babirye J, McCann L PLoS Pathog. 2022; 18(7):e1010721.
PMID: 35877763 PMC: 9352196. DOI: 10.1371/journal.ppat.1010721.
GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.
Kumar A, Taghi Khani A, Sanchez Ortiz A, Swaminathan S Front Immunol. 2022; 13:901277.
PMID: 35865534 PMC: 9294178. DOI: 10.3389/fimmu.2022.901277.
An update on GM-CSF and its potential role in melanoma management.
Dillman R Melanoma Manag. 2020; 7(3):MMT49.
PMID: 32922731 PMC: 7475793. DOI: 10.2217/mmt-2020-0011.